PI3K inhibition sensitize cancer cells to tumor treating fields (TTFields)

被引：0
|
作者：
Klein-Goldberg, Anat
Voloshin, Tali
Zemer-Tov, Efrat
Paz, Rom
Koren, Lilach
Wainer-Katsir, Kerem
Volodin, Alexandra
Koltun, Bella
Brant, Boris
Barsheshet, Yiftah
Kan, Tal
David, Cfir
Khalil, Tharwat Haj
Haber, Adi
Giladi, Moshe
Weinberg, Uri
Palti, Yoram
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4860
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4860
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells
    Frasson, Chiara
    Rampazzo, Elena
    Accordi, Benedetta
    Beggio, Giacomo
    Pistollato, Francesca
    Basso, Giuseppe
    Persano, Luca
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [42] The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells
    Glorieux, Mary
    Dok, Ruveyda
    Nuyts, Sandra
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [43] The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells
    Mary Glorieux
    Rüveyda Dok
    Sandra Nuyts
    Scientific Reports, 10
  • [44] Tumor treating fields (TTFields) reduce migration and invasion properties of human glioma cancer cells in vitro
    Schneiderman, Rosa S.
    Shteingauz, Anna
    Giladi, Moshe
    Voloshin, Tali
    Porat, Yaara
    Munster, Mijal
    Blat, Roni
    Kirson, Eilon D.
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2016, 76
  • [45] Enhancing Cancer Cell Membrane Permeability by Application of Tumor Treating Fields (TTFields)
    Koltun, B.
    Voloshin, T.
    Kan, T.
    David, C.
    Koren, L.
    Porat, Y.
    Volodin, A.
    Kaynan, N.
    Klein-Goldberg, A.
    Paz, R.
    Brant, B.
    Barsheshet, Y.
    Zemer-Tov, E.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E520 - E521
  • [46] Preclinical effects of Tumor Treating Fields (TTFields) with PARP inhibitors in ovarian cancer
    Berckmans, Yani
    Ene, Hila
    Ben-Meir, Kerem
    Martinez-Conde, Antonia
    Monin, Roni
    Van den Ende, Bieke
    Van Mechelen, Sara
    Frechtel-Gerzi, Roni
    Gabay, Hila
    Engelman, Rotem
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    Vergote, Ignace
    Coosemans, An
    CANCER RESEARCH, 2024, 84 (06)
  • [47] PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
    Falasca, Marco
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (12) : 1410 - 1416
  • [48] PI3K Inhibition Sensitize the Cisplatin-resistant Human Ovarian Cancer Cell OVCAR3 by Induction of Oxidative Stress
    Baghal-Sadriforoush, Sahar
    Bagheri, Morteza
    Rad, Isa Abdi
    Nejadnematalahi, Fattah Sotoodeh
    REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2022, 10 (04): : 675 - 685
  • [49] GLIOBLASTOMA CELLS FROM A PATIENT POST-TUMOR TREATING FIELDS (TTFIELDS) THERAPY ARE SENSITIVE TO TTFIELDS IN VITRO
    Michelhaugh, Sharon K.
    Kiousis, Sam
    Mittal, Sandeep
    NEURO-ONCOLOGY, 2017, 19 : 87 - 87
  • [50] Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway
    Shan, Hui
    Zhang, Xin
    Mi, Yalu
    Jia, Jihui
    Wang, Bo
    Yang, Qing
    PHARMACEUTICALS, 2022, 15 (12)
12345